Clinical Trial Detail

NCT ID NCT02395172
Title Avelumab in Non-Small Cell Lung Cancer (JAVELIN Lung 200)
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements yes
Sponsors EMD Serono Research & Development Institute, Inc.
Indications

non-small cell lung carcinoma

Therapies

Avelumab

Docetaxel

Age Groups: adult

Additional content available in CKB BOOST